Amygdalin as a Promising Anticancer Agent: Molecular Mechanisms and Future Perspectives for the Development of New Nanoformulations for Its Delivery
International Journal of Molecular Sciences · 19.09.2023 · 24 (18) · 14270
DOI: 10.3390/ijms241814270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.09.2023. Verfasst von Maria Spanoudaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 54700 Sindos, Greece. Hauptthemen laut MEDLINE: Amygdalin, Neoplasms, Antineoplastic Agents, Antineoplastic Agents, Phytogenic. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer rates are increasing, and cancer is one of the main causes of death worldwide. Amygdalin, also known as vitamin B17 (and laetrile, a synthetic compound), is a cyanogenic glycoside compound that is mainly found in the kernels and pulps of fruits. This compound has been proposed for decades as a promising naturally occurring substance which may provide anticancer effects. This is a comprehensive review which critically summarizes and scrutinizes the available studies exploring the anticancer effect of amygdalin, highlighting its potential anticancer molecular mechanisms as well as the need for a nontoxic formulation of this substance. In-depth research was performed using the most accurate scientific databases, e.g., PubMed, Cochrane, Embase, Medline, Scopus, and Web of Science, applying effective, characteristic, and relevant keywords. There are several pieces of evidence to support the idea that amygdalin can exert anticancer effects against lung, breast, prostate, colorectal, cervical, and gastrointestinal cancers. Amygdalin has been reported to induce apoptosis of cancer cells, inhibiting cancer cells’ proliferation and slowing down tumor metastatic spread. However, only a few studies have been performed in in vivo animal models, while clinical studies remain even more scarce. The current evidence cannot support a recommendation of the use of nutritional supplements with amygdalin due to its cyano-moiety which exerts adverse side effects. Preliminary data have shown that the use of nanoparticles may be a promising alternative to enhance the anticancer effects of amygdalin while simultaneously reducing its adverse side effects. Amygdalin seems to be a promising naturally occurring agent against cancer disease development and progression. However, there is a strong demand for in vivo animal studies as well as human clinical studies to explore the potential prevention and/or treatment efficiency of amygdalin against cancer. Moreover, amygdalin could be used as a lead compound by effectively applying recent developments in drug discovery processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 54700 Sindos, Greece.
- Clinical Dietetics and Nutritional Department, 424 General Military Hospital, 56429 Thessaloniki, Greece.
- Department of Nutrition and Dietetics, School of Physical Education, Sport Science and Dietetics, University of Thessaly, 42132 Trikala, Greece.
- Orthopedic Department, 424 General Military Hospital, 56429 Thessaloniki, Greece.
- Laboratory of Plant Physiology and Postharvest Physiology of Fruits, Department of Agriculture, International Hellenic University, 54700 Sindos, Greece.
- Department of Food Science and Nutrition, School of Environment, University of Aegean, 81400 Lemnos, Greece.
ORCID-Profile: Sousana K Papadopoulou, Constantinos Giaginis
Zitieren
APA
Spanoudaki, M., Stoumpou, S., Papadopoulou, S. K., Karafyllaki, D., Solovos, E., Papadopoulos, K., Giannakoula, A., & Giaginis, C. (2023). Amygdalin as a Promising Anticancer Agent: Molecular Mechanisms and Future Perspectives for the Development of New Nanoformulations for Its Delivery. International Journal of Molecular Sciences, 24(18), 14270. https://doi.org/10.3390/ijms241814270
Vancouver
Spanoudaki M, Stoumpou S, Papadopoulou SK, Karafyllaki D, Solovos E, Papadopoulos K, et al. Amygdalin as a Promising Anticancer Agent: Molecular Mechanisms and Future Perspectives for the Development of New Nanoformulations for Its Delivery. International Journal of Molecular Sciences. 2023;24(18):14270. doi:10.3390/ijms241814270
BibTeX
@article{Spanoudaki2023,
author = {Spanoudaki, Maria and Stoumpou, Sofia and Papadopoulou, Sousana K and Karafyllaki, Dimitra and Solovos, Evangelos and Papadopoulos, Konstantinos and Giannakoula, Anastasia and Giaginis, Constantinos},
title = {Amygdalin as a Promising Anticancer Agent: Molecular Mechanisms and Future Perspectives for the Development of New Nanoformulations for Its Delivery},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {18},
pages = {14270},
doi = {10.3390/ijms241814270}
}
EUVIMED